Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T CellsHadas Weinstein-Marom, Noam Levin, Aviad Pato, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Frontiers in Immunology|October 20, 2025
Differential effects of immobilized CCL21 and ICAM1 on TILs with distinct expansion propertiesSofi Yado, Rawan Zoabi, Karin Brezinger-Dayan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 17, 2011
Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetesA G Jones, R E J Besser, T J McDonald, et al.
Wellcome Open Research|February 10, 2025
A study to determine a capillary alternative to the gold standard oral glucose tolerance test - ProtocolRabbi Swaby, Claire Scudder, Tabitha Randell, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell LinesHadas Weinstein-Marom, Dayana Blokon-Kogan, Maya Levi-Mann, et al.
Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.
Pediatric Diabetes|January 8, 2013
Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetesRachel E J Besser, Beverley M Shields, Suzanne E Hammersley, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Pageof 15